PRN: Cannabis 2.0: Canada Set to Legalize CBD Topicals and Beverages October 17, 2019

15/ott/2019 11:30:09 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Cannabis 2.0: Canada Set to Legalize CBD Topicals and Beverages October 17, 2019

 
[15-October-2019]
 

Financialnewsmedia.com News Commentary

PALM BEACH, Florida, Oct. 15, 2019 /PRNewswire/ -- Over the next three days, Canada will legalize CBD all over again. Just a year after legalizing dried cannabis flower, oils, and sprays, Canada will now legalize edibles, beverages, and topicals this Thursday, October 17, potentially creating sizable opportunity for growth. Interesting to note, according to analysts at Deloitte, up to 60% of Canadians would use cannabis edible products. That's opening a wide range of opportunity for companies including The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF), Aphria Inc. (NYSE:APHA) (TSX:APHA), Charlotte's We! b Holding s Inc. (CSE:CWEB) (OTCQX:CWBHF), OrganiGram Holdings Inc. (TSX-V:OGI) (NASDAQ:OGI), and GW Pharmaceuticals PLC (NASDAQ:GWPH).

The Yield Growth Corp. (CSE:BOSS)(OTCQB:BOSQF) BREAKING NEWS: The Yield Growth Corp. just announced the appointment of Amber Allen as Head of Sales for Yield Growth's North American retail distribution. Ms. Allen is a seasoned and savvy sales broker bringing decades of experience working with distributors to grow a multitude of brands in the skincare, edible mushrooms and other wellness spaces, including Lavido Skin Care, Love Chock, My Matcha Life, Four Sigmatic, Sun Warrior, Mikei Red Reishi, Thursday Plantation and Kosmea Skin Care. As part of the Yield Growth team, Amber will be tasked with refining the company's sales strategy to maximize sales in Canada and the USA with new and existing acc! ounts, le veraging her expansive and long-standing relationships with skincare and wellness retail distributors cultivated over 15 years in the profession. "Amber's qualifications in selling wellness products for both skin care lines and edible mushroom brands make her an ideal candidate to build out our North American retail presence," says Penny White, CEO of Yield Growth. "Amber's experience in building out the sales platform for North American brands is particularly interesting as we prepare to launch out wild edible mushroom brand through our subsidiary Flourish Mushroom Labs." Amber Allen is the founder of Amber Naturally, a boutique creative firm specializing in sales consulting, social media, content marketing, design, and marketing for natural health and wellness brands. She began her career over fifteen years ago as a personal trainer and nutritionist in Vancouver British Columbia! , before parlaying her passion for natural healing into her studies of herbalism and wellness.

Other cannabis-related developments from around the markets include:

Aphria Inc. (NYSE:APHA) (TSX:APHA) will release results for the first quarter and three months ended August 31, 2019 on October 15, 2019 before market open. Aphria executives will host a conference call to discuss these results at 9:00 am ET. To listen to the live call, dial (888) 231-8191 from Canada and the U.S. or (647) 427-7450 from International locations and use the passcode 6099303. A telephone replay will be available approximately two hours after the call concludes through October 29, 2019.

Charlotte's Web Holdings Inc. (CSE:CWEB)(OTCQX:CWBHF) and Nielsen just announced an analytic relationship between the world's leading CBD brand with the world's leading market intelligence company. Together, Nielsen and Charlotte's Web will help guide the U.S. retail market for consumer-packaged goods (CPG) companies through the evolution of the CBD space. Mirroring the changing tide happening across the U.S. retail and CPG industry, this new relationship marks an open and symbiotic relationship that is forming between the emerging CBD industry and the U.S. retail and manufacturing community. Charlotte's Web is an industry pione! er and th e market leader of hemp-CBD extract products. Leveraging its deep product knowledge and category vision, this new relationship will provide unprecedented visibility into market-leading trends, highlighting segments, brands and products that are resonating with consumers in the CBD market. This alliance will also provide insight into consumer attitudes, product preferences, use occasions and future intent tied to consumer interaction points within CPG categories which will help establish Charlotte's Web as thought leaders and category captains of the hemp CBD category. Collectively, this powerful suite of information will enable U.S. CPG manufacturers and retailers to more easily measure and predict the impact of hemp CBD on the CPG industry and strategize accordingly. The announcement with Charlotte's Web comes as Nielsen steadily develops a full suite of cannabis measurement capabilities, inclusive of strate! gic allia nces such as the one with Headset, the leading data and analytics service provider measuring and analyzing the legal Cannabis dispensary channel.

OrganiGram Holdings Inc. (TSXV:OGI)(NASDAQ:OGI) just announced the Company was recognized at the Excellence in Manufacturing Consortium Awards of Excellence ceremony in Toronto on October 9. Organigram was honored with an Outstanding Member Contribution Award for delivering exemplary support to the EMC over the course of the Company's membership. The award, accepted by Organigram Senior Vice President of Operational Services, Jeff Purcell, recognizes organizations which demonstrate outstanding achievement in manufacturing. "Producing high-quality cannabis in a state-of-the-art indoor environment, Organigram operates in an interesting cross-section of horticulture, consumer packaged goods and manufacturing," Purce! ll said. "We are very proud to accept this award and support EMC, a group that sets the standard for manufacturing excellence in Canada." Organigram was additionally nominated as a finalist in the awards' Outstanding Manufacturer category.

GW Pharmaceuticals PLC (NASDAQ:GWPH) will announce on November 5th, 2019 its financial results for the third quarter ending September 30th, 2019. GW will also host a conference call the same day at 4:30 p.m. ET. Conference call information will be provided in the financial results press release. A replay of the call will also be available through the Company's website shortly after the call.

DISCLAIMER: FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third- party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of i! nvesting in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM expects to be compensated three thousand six hundred dollars for news coverage of current press releases issued by The Yield Growth Corp. by a non-affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks iden! tified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:

Media Contact email:
editor@financialnewsmedia.com
+1(561)325-8757

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl